Obesity and other metabolic conditions are contributing to a significant increase in health issues worldwide. Many employers are now experiencing a sharp increase in utilization of anti-obesity medications, including GLP–1 drugs. Join the Brown & Brown Population Health & Well-Being team and our distinguished guest speakers in a three-part webinar series on strategies to help […]